BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 34264137)

  • 1. Delayed diagnosis of critical congenital heart defects predicting risk factors and survival rate in newborns in Beijing: a retrospective study.
    Zhang W; Xu HY; Zhang YC; Liu KB
    J Int Med Res; 2021 Jul; 49(7):3000605211028028. PubMed ID: 34264137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in Delayed Diagnosis of Critical Congenital Heart Defects in an Era of Enhanced Screening, 2004-2018.
    Liberman RF; Heinke D; Lin AE; Nestoridi E; Jalali M; Markenson GR; Sekhavat S; Yazdy MM
    J Pediatr; 2023 Jun; 257():113366. PubMed ID: 36858148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Assessment of undiagnosed critical congenital heart disease before discharge from the maternity hospital].
    Zhao QM; Liu F; Wu L; Ye M; Jia B; Ma XJ; Huang GY
    Zhonghua Er Ke Za Zhi; 2017 Apr; 55(4):260-266. PubMed ID: 28441821
    [No Abstract]   [Full Text] [Related]  

  • 4. Factors associated with late detection of critical congenital heart disease in newborns.
    Dawson AL; Cassell CH; Riehle-Colarusso T; Grosse SD; Tanner JP; Kirby RS; Watkins SM; Correia JA; Olney RS
    Pediatrics; 2013 Sep; 132(3):e604-11. PubMed ID: 23940249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed diagnosis of critical congenital heart defects: trends and associated factors.
    Liberman RF; Getz KD; Lin AE; Higgins CA; Sekhavat S; Markenson GR; Anderka M
    Pediatrics; 2014 Aug; 134(2):e373-81. PubMed ID: 25070301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of routine screening for critical congenital heart disease in US newborns.
    Peterson C; Grosse SD; Oster ME; Olney RS; Cassell CH
    Pediatrics; 2013 Sep; 132(3):e595-603. PubMed ID: 23918890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early screening for critical congenital heart defects in asymptomatic newborns in Bursa province.
    Özalkaya E; Akdağ A; Şen I; Cömert E; Melek Yaren H
    J Matern Fetal Neonatal Med; 2016; 29(7):1105-7. PubMed ID: 25902399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal diagnosis and prevalence of critical congenital heart defects: an international retrospective cohort study.
    Bakker MK; Bergman JEH; Krikov S; Amar E; Cocchi G; Cragan J; de Walle HEK; Gatt M; Groisman B; Liu S; Nembhard WN; Pierini A; Rissmann A; Chidambarathanu S; Sipek A; Szabova E; Tagliabue G; Tucker D; Mastroiacovo P; Botto LD
    BMJ Open; 2019 Jul; 9(7):e028139. PubMed ID: 31270117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulse oximetry screening for critical congenital heart disease: a comparative study of cohorts over 11 years.
    Banait N; Ward-Platt M; Abu-Harb M; Wyllie J; Miller N; Harigopal S
    J Matern Fetal Neonatal Med; 2020 Jun; 33(12):2064-2068. PubMed ID: 30332903
    [No Abstract]   [Full Text] [Related]  

  • 10. Beyond Critical Congenital Heart Disease: Newborn Screening Using Pulse Oximetry for Neonatal Sepsis and Respiratory Diseases in a Middle-Income Country.
    Jawin V; Ang HL; Omar A; Thong MK
    PLoS One; 2015; 10(9):e0137580. PubMed ID: 26360420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prenatal and newborn screening for critical congenital heart disease: findings from a nursery.
    Johnson LC; Lieberman E; O'Leary E; Geggel RL
    Pediatrics; 2014 Nov; 134(5):916-22. PubMed ID: 25287457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulse oximetry as a screening test for critical congenital heart disease in term newborns.
    Gómez-Rodríguez G; Quezada-Herrera A; Amador-Licona N; Carballo-Magdaleno D; Rodríguez-Mejía EJ; Guízar-Mendoza JM
    Rev Invest Clin; 2015; 67(2):130-4. PubMed ID: 25938847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of pulse oximetry in examining newborns for congenital heart disease: a scientific statement from the AHA and AAP.
    Mahle WT; Newburger JW; Matherne GP; Smith FC; Hoke TR; Koppel R; Gidding SS; Beekman RH; Grosse SD; ; ;
    Pediatrics; 2009 Aug; 124(2):823-36. PubMed ID: 19581259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early screening for critical congenital heart defects in asymptomatic newborns in Mazovia province: experience of the POLKARD pulse oximetry programme 2006-2008 in Poland.
    Turska Kmieć A; Borszewska Kornacka MK; Błaż W; Kawalec W; Zuk M
    Kardiol Pol; 2012; 70(4):370-6. PubMed ID: 22528711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hospitalizations, costs, and mortality among infants with critical congenital heart disease: how important is timely detection?
    Peterson C; Dawson A; Grosse SD; Riehle-Colarusso T; Olney RS; Tanner JP; Kirby RS; Correia JA; Watkins SM; Cassell CH
    Birth Defects Res A Clin Mol Teratol; 2013 Oct; 97(10):664-72. PubMed ID: 24000201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can echocardiographic screening in the early days of life detect critical congenital heart disease among apparently healthy newborns?
    Kondo M; Ohishi A; Baba T; Fujita T; Iijima S
    BMC Pediatr; 2018 Nov; 18(1):359. PubMed ID: 30453920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of pulse oximetry in examining newborns for congenital heart disease: a scientific statement from the American Heart Association and American Academy of Pediatrics.
    Mahle WT; Newburger JW; Matherne GP; Smith FC; Hoke TR; Koppel R; Gidding SS; Beekman RH; Grosse SD; ;
    Circulation; 2009 Aug; 120(5):447-58. PubMed ID: 19581492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of critical congenital heart disease among newborns in Argentina through the national surveillance system of congenital heart disease (RENAC).
    Groisman B; Barbero P; Liascovich R; Brun P; Bidondo MP
    Arch Argent Pediatr; 2022 Feb; 120(1):6-13. PubMed ID: 35068114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulse oximetry findings in newborns with antenatally diagnosed congenital heart disease.
    Mawson IE; Babu PL; Simpson JM; Fox GF
    Eur J Pediatr; 2018 May; 177(5):683-689. PubMed ID: 29404717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulse Oximetry Screening Has Not Changed Timing of Diagnosis or Mortality of Critical Congenital Heart Disease.
    Campbell MJ; Quarshie WO; Faerber J; Goldberg DJ; Mascio CE; Blinder JJ
    Pediatr Cardiol; 2020 Jun; 41(5):899-904. PubMed ID: 32107587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.